Tectonic Therapeutic (TECX) Gains from Sales and Divestitures (2018 - 2026)
Tectonic Therapeutic (TECX) has 9 years of Gains from Sales and Divestitures data on record, last reported at $51282.0 in Q1 2026.
- On a quarterly basis, Gains from Sales and Divestitures changed N/A to $51282.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $51282.0, a N/A change, with the full-year FY2025 number at $7561.0, down 70.72% from a year prior.
- Gains from Sales and Divestitures reached $51282.0 in Q1 2026 per TECX's latest filing, up from $7561.0 in the prior quarter.
- Over the last five years, Gains from Sales and Divestitures for TECX hit a ceiling of $305502.0 in Q4 2023 and a floor of $143.0 in Q1 2022.
- A 5-year average of $83301.1 and a median of $18968.0 in 2024 define the central range for Gains from Sales and Divestitures.
- Peak YoY movement for Gains from Sales and Divestitures: soared 88213.59% in 2023, then tumbled 93.32% in 2024.
- Tracing TECX's Gains from Sales and Divestitures over 5 years: stood at $575.0 in 2022, then skyrocketed by 53030.78% to $305502.0 in 2023, then tumbled by 91.55% to $25827.0 in 2024, then crashed by 70.72% to $7561.0 in 2025, then surged by 578.24% to $51282.0 in 2026.
- Business Quant data shows Gains from Sales and Divestitures for TECX at $51282.0 in Q1 2026, $7561.0 in Q4 2025, and $2930.0 in Q3 2025.